Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 29, 2018
RedHill Biopharma to Present at BMO 2018 Prescriptions for Success Healthcare Conference
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty ...
November 29, 2018
Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories
BUFFALO, N.Y., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
November 29, 2018
Zogenix to Host Investor Update Lunch on FINTEPLA® at the American Epilepsy Society 2018 Annual Meeting
EMERYVILLE, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare diseases, today announced that ...
November 29, 2018
NOX Announces Positive Data from CEP-1 Study of Veyonda®
SYDNEY, Australia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Noxopharm (ASX:NOX) announces the final results from its Phase 1b CEP-1 trial evaluating its lead immuno-oncology/radio-enhancer drug ...
November 29, 2018
BioTime to Present at the LD Micro 11th Annual Main Event Investor Conference on December 5th, 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that Brian M. Culley, Chief Executive Officer of ...
November 29, 2018
BioTime Announces Distribution of AgeX Therapeutics Shares
BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that the registration statement on Form 10, including ...
November 29, 2018
InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard™ EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)
TEL AVIV, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
November 29, 2018
Spring Bank Announces Additional Pre-Clinical Data on Its Second-Generation STING Agonist Program at the AACR Special Conference on Tumor Immunology and Immunotherapy
HOPKINTON, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
November 29, 2018
Elements Behavioral Health Announces Adoption of Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression in Tennessee Facility
NUNNELLY, Tenn., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Elements Behavioral Health, the owner of behavioral health programs located throughout the United States, announced today that ...
November 28, 2018
Sierra Oncology to Host Analyst Call Highlighting Clinical Data on Momelotinib's Anemia Benefit
VANCOUVER , Nov. 27, 2018 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment ...
November 28, 2018
Prometic Provides Corporate Update
LAVAL, QC , Nov 28, 2018 /CNW Telbec/ -  Prometic Life Sciences Inc. (PLI.TO) (PFSCF)("Prometic" or the "Corporation") has previously announced a series of initiatives to ...
November 28, 2018
Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy
NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a company focused on the development of novel immunotherapies based on proprietary ...
November 28, 2018
BioTime Announces Distribution of AgeX Therapeutics Shares
BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that the registration statement on Form 10, including ...
November 28, 2018
InspireMD Announces Regulatory and Reimbursement Approval of CGuard™ Embolic Prevention System in Australia
TEL AVIV, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
November 27, 2018
OSE Immunotherapeutics Receives Belgian Authorization for a Phase 1 Clinical Trial to Evaluate Anti-IL-7 Receptor Antagonist OSE-127
NANTES, France, Nov. 26, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA(ISIN: FR0012127173; Mnémo: OSE) today announced authorization by Federal Agency for Medicines and Health Products (FAMH) ...
November 27, 2018
iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018
NASHUA, N.H. and CHICAGO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- (Booth #3911 and #8161) – iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer ...
November 27, 2018
Tyme Technologies, Inc. to Present at the Piper Jaffray Healthcare Conference on November 28th
NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, ...
November 27, 2018
Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences
AUSTIN, Texas, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s ...
November 27, 2018
Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will host a webcast and conference call on December 11, 2018, at 4:30 p.m. EST ...
November 27, 2018
Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor
DUBLIN, Nov. 27, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of the first subject in a Phase ...
Page 3 of 117